Literature DB >> 2571851

Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

S Vento, G Di Perri, T Garofano, L Cosco, E Concia, T Ferraro, D Bassetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2571851     DOI： 10.1016/s0140-6736(89)91595-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 2.  Immunological abnormalities and hepatotropic viral infections.

Authors:  I G McFarlane
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

3.  A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome.

Authors:  Ashaur Azhar; Mumtaz A Niazi; Kashif Tufail; Ashraf H Malek; Manjula Balasubramanian; Victor Araya
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

4.  Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.

Authors:  J Cianciara; T Laskus
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.

Authors:  N Kumagai; S Kuramochi; K Toda; N Iwabuchi; K Tsuchimoto; S Tsunematsu; H Saito; T Morizane; M Tsuchiya; H Ishii
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

Review 6.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

7.  Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.

Authors:  H Unoki; A Moriyama; A Tabaru; A Masumoto; M Otsuki
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 8.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

9.  Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis.

Authors:  K H Meyer zum Büschenfelde; U Treichel; H Löhr; B Fleischer; T Poralla
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 10.  Diagnostic markers of viral hepatitis B and C.

Authors:  C Trépo; F Zoulim; C Alonso; M A Petit; C Pichoud; L Vitvitski
Journal:  Gut       Date:  1993       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.